CG Oncology (CGON) Other financing activities (2023 - 2026)
CG Oncology (CGON) posted Other financing activities of $1.7 million for Q1 2026, up 154.42% on a QoQ basis from $656000.0 in Q4 2025, and up 144.72% year-over-year from $682000.0 in Q1 2025.
CG Oncology (CGON) Other financing activities (2023 - 2026) Analysis & Trends
CG Oncology's Other financing activities history runs 4 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- Quarterly Other financing activities rose 144.72% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.4 million (up 991.35% YoY) and the FY2025 annual result came in at $6.5 million, down 98.41% from the prior year.
- Other financing activities was $1.7 million for Q1 2026 at CG Oncology, up from $656000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $406.4 million in Q1 2024 and bottomed at $19000.0 in Q2 2025.
- A 4-year average of $41.7 million and a median of $669000.0 in 2025 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2024 — Other financing activities jumped 597561.76% — and 2025, when it sank 99.83%.
- CG Oncology's Other financing activities stood at $262000.0 in 2023, then surged by 155018.32% to $406.4 million in 2024, then tumbled by 99.84% to $656000.0 in 2025, then jumped by 154.42% to $1.7 million in 2026.
- Business Quant data shows CGON's Other financing activities at $1.7 million in Q1 2026, $656000.0 in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CG Oncology | 6.01 Bn | 6.01 Bn | -1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.67 Mn |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 656,000.00 |
| Dec 31, 2025 | 656,000.00 |
| Sep 30, 2025 | 5.10 Mn |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 682,000.00 |
| Mar 31, 2025 | 682,000.00 |
| Mar 31, 2024 | 406.41 Mn |
| Mar 31, 2024 | 406.41 Mn |
| Dec 31, 2023 | 262,000.00 |
| Dec 31, 2023 | 262,000.00 |
| Sep 30, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 165,000.00 |
| Jun 30, 2023 | 165,000.00 |
| Mar 31, 2023 | 68,000.00 |
| Mar 31, 2023 | 68,000.00 |